• Baijuyi Holdings clarified that financial assets at FVTPL totaled approximately HK$ 28.8 million at December 31, 2025, representing 9.3% of consolidated assets.
• World Biotech was the largest investment, valued at approximately HK$ 15.32 million, or 4.93% of consolidated assets.
• Kingkey Fund's carrying value fell to approximately HK$ 5.62 million from HK$ 6.8 million at December 31, 2024, primarily reflecting fair-value changes.
• The group favors long-term capital appreciation but retains flexibility to sell or redeem investments.
• A 25% decline from initial investment cost triggers an Investment Committee meeting to consider holding, reducing or disposing of the investment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baijuyi Holdings Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261112-12410075), on November 12, 2026, and is solely responsible for the information contained therein.